229 related articles for article (PubMed ID: 34607845)
1. Incidence and mortality rates of keratinocyte carcinoma from 1998-2017: a population-based study of sex differences in Ontario, Canada.
Tang E; Fung K; Chan AW
CMAJ; 2021 Oct; 193(39):E1516-E1524. PubMed ID: 34607845
[TBL] [Abstract][Full Text] [Related]
2. Application of Recursive Partitioning to Derive and Validate a Claims-Based Algorithm for Identifying Keratinocyte Carcinoma (Nonmelanoma Skin Cancer).
Chan AW; Fung K; Tran JM; Kitchen J; Austin PC; Weinstock MA; Rochon PA
JAMA Dermatol; 2016 Oct; 152(10):1122-1127. PubMed ID: 27533718
[TBL] [Abstract][Full Text] [Related]
3. Age group-specific changes in keratinocyte cancer treatment rates in Australia, 2012-2021: a retrospective cohort study based on MBS claims data.
Olsen CM; Pandeya N; Neale RE; Whiteman DC
Med J Aust; 2024 May; 220(9):472-479. PubMed ID: 38685827
[TBL] [Abstract][Full Text] [Related]
4. Association of Age, Sex, Race, and Geographic Region With Variation of the Ratio of Basal Cell to Cutaneous Squamous Cell Carcinomas in the United States.
Lukowiak TM; Aizman L; Perz A; Miller CJ; Sobanko JF; Shin TM; Giordano CN; Higgins HW; Etzkorn JR
JAMA Dermatol; 2020 Nov; 156(11):1192-1198. PubMed ID: 32845319
[TBL] [Abstract][Full Text] [Related]
5. Burden of disease caused by keratinocyte cancer has increased in The Netherlands since 1989.
Hollestein LM; de Vries E; Aarts MJ; Schroten C; Nijsten TE
J Am Acad Dermatol; 2014 Nov; 71(5):896-903. PubMed ID: 25190484
[TBL] [Abstract][Full Text] [Related]
6. The incidence and multiplicity rates of keratinocyte cancers in Australia.
Pandeya N; Olsen CM; Whiteman DC
Med J Aust; 2017 Oct; 207(8):339-343. PubMed ID: 29020905
[TBL] [Abstract][Full Text] [Related]
7. Nationwide Trends in the Incidence of Melanoma and Non-melanoma Skin Cancers from 1999 to 2014 in South Korea.
Oh CM; Cho H; Won YJ; Kong HJ; Roh YH; Jeong KH; Jung KW
Cancer Res Treat; 2018 Jul; 50(3):729-737. PubMed ID: 28707459
[TBL] [Abstract][Full Text] [Related]
8. Association of ACE inhibitors and angiotensin receptor blockers with keratinocyte cancer prevention in the randomized VATTC trial.
Christian JB; Lapane KL; Hume AL; Eaton CB; Weinstock MA;
J Natl Cancer Inst; 2008 Sep; 100(17):1223-32. PubMed ID: 18728281
[TBL] [Abstract][Full Text] [Related]
9. Incidence trends of keratinocytic skin cancers and melanoma in Israel 2006-11.
Sella T; Goren I; Shalev V; Shapira H; Zandbank J; Rosenblum J; Kimlin MG; Chodick G
Br J Dermatol; 2015 Jan; 172(1):202-7. PubMed ID: 24976239
[TBL] [Abstract][Full Text] [Related]
10. [Non-melanoma skin cancer: incidence time trends analysis in Girona, Spain, 1994-2007].
Vilar-Coromina N; Miró-Queralt J; Cano-Bautista A; Vilardell-Gil L; Torres Babié P; Marcos-Gragera R
Med Clin (Barc); 2011 Jul; 137(4):145-51. PubMed ID: 21601891
[TBL] [Abstract][Full Text] [Related]
11. Epidemiology of cutaneous melanoma and keratinocyte cancer in white populations 1943-2036.
Garbe C; Keim U; Gandini S; Amaral T; Katalinic A; Hollezcek B; Martus P; Flatz L; Leiter U; Whiteman D
Eur J Cancer; 2021 Jul; 152():18-25. PubMed ID: 34062483
[TBL] [Abstract][Full Text] [Related]
12. Trends in Non-Melanoma Skin Cancer (Basal Cell Carcinoma and Squamous Cell Carcinoma) in Canada: A Descriptive Analysis of Available Data.
Abbas M; Kalia S
J Cutan Med Surg; 2016; 20(2):166-75. PubMed ID: 26458408
[TBL] [Abstract][Full Text] [Related]
13. Turning the tide? Changes in treatment rates for keratinocyte cancers in Australia 2000 through 2011.
Olsen CM; Williams PF; Whiteman DC
J Am Acad Dermatol; 2014 Jul; 71(1):21-6.e1. PubMed ID: 24685358
[TBL] [Abstract][Full Text] [Related]
14. Algorithms for ascertaining keratinocyte carcinomas using health insurance claims and prescription records.
Zhang T; Lee TK; Lui H; Kunimoto B; Han C; Zhou Y; Kalia S
J Eur Acad Dermatol Venereol; 2019 Aug; 33(8):e275-e276. PubMed ID: 30762901
[No Abstract] [Full Text] [Related]
15. Trends of keratinocyte carcinoma mortality rates in the United States as reported on death certificates, 1999 through 2010.
Wu W; Weinstock MA
Dermatol Surg; 2014 Dec; 40(12):1395-401. PubMed ID: 25393350
[TBL] [Abstract][Full Text] [Related]
16. Spectrum of Immune-Related Conditions Associated with Risk of Keratinocyte Cancers among Elderly Adults in the United States.
Yanik EL; Pfeiffer RM; Freedman DM; Weinstock MA; Cahoon EK; Arron ST; Chaloux M; Connolly MK; Nagarajan P; Engels EA
Cancer Epidemiol Biomarkers Prev; 2017 Jul; 26(7):998-1007. PubMed ID: 28377416
[No Abstract] [Full Text] [Related]
17. Mortality trend of cutaneous melanoma in Montenegro from 1990-2018.
Nedovic Vukovic M; Terzic Z; Golubovic M; Bojic M; Bukumiric Z
Eur Rev Med Pharmacol Sci; 2024 May; 28(9):3463-3472. PubMed ID: 38766804
[TBL] [Abstract][Full Text] [Related]
18. Incidence Estimate of Nonmelanoma Skin Cancer (Keratinocyte Carcinomas) in the U.S. Population, 2012.
Rogers HW; Weinstock MA; Feldman SR; Coldiron BM
JAMA Dermatol; 2015 Oct; 151(10):1081-6. PubMed ID: 25928283
[TBL] [Abstract][Full Text] [Related]
19. Trends in keratinocyte skin cancer incidence, mortality and burden of disease in 33 countries between 1990 and 2017.
Yang DD; Borsky K; Jani C; Crowley C; Rodrigues JN; Matin RN; Marshall DC; Salciccioli JD; Shalhoub J; Goodall R
Br J Dermatol; 2023 Feb; 188(2):237-246. PubMed ID: 36763862
[TBL] [Abstract][Full Text] [Related]
20. Exclusive development of a single type of keratinocyte skin cancer: evidence from an Australian population-based cohort study.
Keim U; van der Pols JC; Williams GM; Green AC
J Invest Dermatol; 2015 Mar; 135(3):728-733. PubMed ID: 25233075
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
